BioRestorative Therapies (OTCMKTS:BRTX) Trading Down 3.8%

BioRestorative Therapies Inc (OTCMKTS:BRTX)’s share price was down 3.8% during trading on Friday . The company traded as low as $0.31 and last traded at $0.35, approximately 49,286 shares were traded during trading. A decline of 63% from the average daily volume of 131,665 shares. The stock had previously closed at $0.36.

The stock has a 50-day moving average of $0.28 and a 200 day moving average of $0.47.

In related news, major shareholder Dale Broadrick acquired 175,017 shares of the firm’s stock in a transaction that occurred on Thursday, August 22nd. The shares were bought at an average cost of $0.28 per share, for a total transaction of $49,004.76. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Over the last 90 days, insiders purchased 349,696 shares of company stock worth $94,774. 20.60% of the stock is owned by company insiders.

BioRestorative Therapies Company Profile (OTCMKTS:BRTX)

BioRestorative Therapies, Inc develops therapeutic products and medical therapies using cell and tissue protocols, primarily involving adult stem cells for the treatment of disc/spine disease and metabolic disorders. The company's lead cell therapy candidate is the BRTX-100, which focuses on providing non-surgical treatment for protruding and bulging lumbar discs in patients suffering from chronic lumbar disc disease.

Featured Story: What is a resistance level?

Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit